Cost-effectiveness analysis of additional abiraterone for hormone-sensitive metastatic prostatic cancer treated with androgen deprivation therapy (ADT)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 28; p. x77
Main Authors Chiang, C.L., Choi, H., Mui, W.H., So, T.H.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.11.2017
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdx662